Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution?

Paul D. Brown; Manmeet S. Ahluwalia; Osaama H. Khan; Anthony L. Asher; Jeffrey S. Wefel; Vinai Gondi

doi:10.1200/JCO.2017.75.9589

Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution?

Paul D. Brown
, Manmeet S. Ahluwalia
, Osaama H. Khan
, Anthony L. Asher
, Jeffrey S. Wefel
, Vinai Gondi

Herbert Wertheim Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	36
DOIs	https://doi.org/10.1200/JCO.2017.75.9589
State	Published - Dec 22 2017

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1200/JCO.2017.75.9589License: Unspecified

Cite this

@article{62d22e1d46ee4b1a91ea106d1de19bbe,

title = "Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution?",

author = "Brown, \{Paul D.\} and Ahluwalia, \{Manmeet S.\} and Khan, \{Osaama H.\} and Asher, \{Anthony L.\} and Wefel, \{Jeffrey S.\} and Vinai Gondi",

note = "An estimated 20\% of patients with cancer will develop brain metastases. Approximately 200,000 individuals in the United States alone receive whole-brain radiotherapy (WBRT) each year to treat brain metastases. Historically, the prognosis of patients with brain metastases has been poor; however, with new therapies, this is changing.",

year = "2017",

month = dec,

day = "22",

doi = "10.1200/JCO.2017.75.9589",

language = "American English",